Electrotherapy Market Profile, Growth Impact and Demand by Regions

 Electrotherapy Market Overview

The evolution patterns are revised in tandem to the customer likings to realize the greatest growth, and in the long run, viability. The framework for growth plans also has stimulated the market for potential new entrants. The market contenders are making considerable adjustments to minimize the incidence of competitive disadvantage. The market is also well equipped to meet the challenges and keep up with the dynamic growth trends effectively.

The Electrotherapy Market Trends will grow at a CAGR of 4.2% and expected to reach USD 1.11 billion by the end of the forecast period (2017-2023). The electrotherapy market is expected to witness significant growth due to increased inclination of customers towards drug-free methods of treatment and rising awareness about benefits of electrotherapy is anticipated to provide more avenues for growth in the upcoming forecast period. The rise in the acceptance of physiotherapy for treating various ailments has also bolstered the demand for electrotherapy globally. The upsurge in the number of cases related to soft tissue injuries and muscles impairments are increasing the demand for electrotherapy devices.

Electrotherapy Market Segmental Analysis:

The electrotherapy market has been segmented based on

• Type
• Devices
• Application
• Region

Based on type, the market is segmented into

• Interferential
• Extracorporeal Shock Wave Therapy
• Magnetic Field Therapy (Pulsed Electro-Magnetic Field Energy, Constant Energy Magnets)
• Transcutaneous Electrical Nerve Stimulation (TENS) Therapy (Intense TENS, Conventional TENS, Acupuncture-like TENS (AL-TENS))
• Ultrasound Therapy

The regions covered in the market are Europe, North America, Asia Pacific, Africa, and the Middle East.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/3185

Electrotherapy Market Competitive Analysis:

The electrotherapy market leading companies are Eme srl (Italy), BTL (Czech Republic), EMS Physio Ltd. (UK), Medtronic (Republic of Ireland), Enraf-Nonius B.V.(Netherlands), Pure Care (US), gbo Medizintechnik AG (Germany), Phoenix Healthcare (UK), Omron Healthcare, Inc. (US), Walgreen Co. (US), STYMCO Technologies, LLC (US) and others

Electrotherapy Market Regional Analysis:

The regional analysis of the electrotherapy market comprises of regions such as North America, Europe, Asia Pacific, Africa, and the Middle East. The North American region is the major market for electrotherapy. In the North America region, the US controls a major market share while the European market is the next major region in the market.

The growth rate is relatively higher in west European countries. Conversely, the Asia Pacific region is a rapidly growing market and is anticipated to control the market by the year 2023. The Middle East and African region are expected to have restrained growth in the market owing to a low-level awareness of the devices and treatment. 

Browse More Details at: https://www.marketresearchfuture.com/reports/electrotherapy-market-3185

The plan formulation process in the market has become significantly easier in which deviations are well accounted for; this approach increases the overall success of these plans in the market. The leadership trends in the market are reinforcing the level of growth that can be achieved in the present market scenario. The alterations seen in terms of strategy execution and creation are altering the development pace of the market.

Browse More Related Research Reports at:

Calciphylaxis Market Research Report Forecast To 2023 | MRFR

Meralgia Paresthetica Market Research Report - Forecast to 2023 | MRFR

Nystagmus Market Size, Application | Dynamics, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +16468459312

Email: sales@marketresearchfuture.com

Cardiopulmonary Resuscitation Market Study of Key Players, Applications and Types

 Cardiopulmonary Resuscitation Market Trends, Growth and Insights- By Product Type (Piston, ACD LDB, ITD), by Use (Ambulance, hospitals, clinics and others), by Compressor type (Manual and Automatic)- Forecast to 2023

Regional Analysis

The global cardiopulmonary resuscitation market has witnessed a significant growth in the Americas owing to its huge population and expanding technological advancements in the region. The large population there includes a prominent number of people suffering from cardiac ailments. A study by the Centers for Disease Control and Prevention revealed that in 2017, almost 610,000 deaths took place in the US, on account of heart ailments. Furthermore, the report states that almost 735,000 Americans suffer heart attack every year. 525,000 out of 735,000 experiences a first heart attack while the rest experiences cardiac arrest for repeated times. Also, key players in the global cardiopulmonary resuscitation market have their focus on holding the huge share of developing markets such as China and India.

The Middle East and Africa and the Asia Pacific regions are considered as lucrative markets by the global cardiopulmonary resuscitation device manufacturers. These markets tend to grow rapidly owing to the surging healthcare outlay and exponential expansion of the patient population.

Besides, nations in these markets look forward to embracing advanced treatment options and progressive technology from the developed economies with the objective of enhancing life quality of the population.

Market Overview

Cardiopulmonary resuscitation is a life saving emergency procedure that integrates artificial ventilation into chest compressions. The technique is meant to cure and support a person who is suffering from cardiac arrest. CPR upholds undisturbed brain functions until further steps are taken to reinstate impulsive breathing and blood circulation in the patient. Even though neurologic outputs and survival rates are not predominantly successful, a proper resuscitation procedure incorporated with apt application and early defibrillation after the cardiac arrest can help enhance the neurological conditions in the patient. Cardiopulmonary resuscitation is also effective in treating the patient through severe cases of drowning.

The growing prevalence of cardiac related ailment population across the world, regardless the age has turned out to be a key factor for the development of the cardiopulmonary resuscitation market. Cardiac related ailments are growing in number due to the increasing adoption of sedentary lifestyle which in turn, results in a substantial obese population.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/1348

A study the World Health Organization (WHO) revealed that in 2015, almost 17.7 million people died from cardiovascular diseases. This number indicates around 31% of the worldwide deaths. An approximate number of 6.7 million out of the 17.7 million were due to stroke and 7.4 million deaths were on account of coronary heart diseases. Another report by World Health Organization (WHO) published in 2016 revealed that over 1.9 billion adults of more than 18 years are overweight. This adds to the chances of developing cardiac related ailments.

Market Segmentation

The global cardiopulmonary resuscitation market has been segmented based on use, compressor type, and product type. Based on use the global cardiopulmonary resuscitation market has been segmented into hospitals, ambulance, organ transplant units, cardiac catheterization laboratories, and clinics. Based on the compressor type the market has been segmented into manual CPR and automatic CPR. The automatic CPR has been sub-segmented into battery operated, mechanically actuated, pneumatic operated, and fully battery operated. Based on the product type, the worldwide cardiopulmonary resuscitation market has been segmented as ACD (Active compression decompression), Piston, ITD (Impedance threshold device), LDB (Load distributing band), Perfusion Devices, Extracoporeal techniques, and Phased thoracic-abdominal compression decompression device.

Browse More Details at: https://www.marketresearchfuture.com/reports/cardiopulmonary-resuscitation-market-1348

Key Players

The global cardiopulmonary resuscitation market has been dominated by key players such as CPR Medical Devices, Inc. (Canada), Cardiac Science Corporation (U.S.), Michigan Instruments (U.S.), General Electric Company (U.S.), Physio-Control, Inc. (U.S.), Koninklijke Philips N.V. (the Netherlands), ZOLL Medical Corporation (which is a part of Asahi Kasei Corporation (Japan)), and St. Jude Medical, Inc. (U.S.).

Wearable Tracking Devices Market Trends, Share, Growth

 Wearable Tracking Devices Market Share, Insights and Growth Analysis by Types (Wrist Wear, Fitness Bands, Foot Wear), Application (Healthcare, Consumer Electronics), Sales Channel (Online, And Offline), End-User (Sports Person, Patients) – Global Forecast Till 2023

Regional Analysis

The Global Wearable Tracking Devices Market covers various regions, namely Americas, Europe, Asia Pacific, and the Middle East and Africa.

Geographically, the market is led by the Americas and is expected to hold the leading position in the future as well. Herein, there lies a huge population suffering from chronic diseases like obesity and diabetes and there is better awareness concerning healthcare that helps increase the demand of the market in this region. The huge patient population in the Americas is expected to drag the players attention towards the market in this region.

Owing to the presence of a huge population affected with chronic diseases, the European market is expected to be huge for such devices. Moreover, the support from the government to enhance the fitness technology and treatment aids them in capturing the global market shares.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/902

The Asia Pacific is another highly popular market that is expected to experience stunning growth in the coming years. In the Asia Pacific region, both India and China are two of the fastest growing regions that are aiding the overall regional market with its proliferating growth. Due to the presence of a massive population and the willingness to invest in better treatment and fitness technologies, the market in these countries are seeing a continuous increase.

Additionally, the countries in this region are on a continuous lookout for integrating these advanced technologies and treatment methodologies from developed nations to reduce the gap between the supply and demand of products. Lastly, the Middle East and Africa are anticipated to expect low market growth in the near future due to the lack of investment therein.

Market Segmentation

The Global Wearable Tracking Devices Market segmentation is based in terms of application, types, sales channel, and end-user.

By type, the market includes footwear, wristwear, and others. The wristwear segment narrows down into fitness bands and smartwatch.

By application, the market comprises of consumer electronics, healthcare, and others.

By sales channel, the market divides into online and offline channels.

By end-user, the market segments into patients, sportsperson, and others.

Competitive Landscape

The Global Wearable Tracking Devices Market comprises of various key players. This includes names such as Pebble Technology Corp (US), Adidas (Germany), Sony (Japan), Apple Inc (US), Gramin Ltd (Switzerland), Google Inc. (US), Samsung Electronics Co Ltd (South Korea), Xiaomi Technology Co., Ltd. (China), Fitbit, Inc. (US), Jawbone (US), Nike (US), and others.

Browse More Details at: https://www.marketresearchfuture.com/reports/wearable-tracking-devices-market-902

Atlas announced that it is coming back into the fitness watch landscape with its latest product, the Multi Trainer 3. The product is capable of tracking more than thousand types of exercises in an automated manner. This tracker aims to be an all-round workout fitness tracker.

Samsung made an announcement to unveil a health-focused smartwatch tracking device, named Galaxy Watch Active. The product boasts the capability to measure and monitor blood-pressure and would cost USD 200.

Overview

As per the latest research conducted by the Market Research Future (MRFR), the Global Wearable Tracking Devices Market is anticipated to attract negligible growth and demand in the forecast period.

These wearable devices aid users by monitoring their health and physical activities. The devices can be worn on the body all the time, 24/7. The device continuously records various data accumulated throughout your day, like your heart rate, step count, quality of sleep, and others. There is an ongoing trend among the young generation concerning these wearable fitness tracking devices, which is a significant factor behind then growth of the market. Moreover, other drivers like the increasing prevalence of cardiovascular diseases, rising awareness concerning fitness, rising cases of obesity, increasing demand for various sophisticated technological devices, and the modernization of lifestyle are expected to add fuel to the market growth of wearable tracking devices. 

However, key factors like the high cost of wearable tracking devices, varying metrics from different devices or lack of consistent results, and security issues are some of the major constraints that can impact the growth of the market.

Nystagmus Market Study of Key Players, Profile and Dynamics

Regional Analysis:

The Americas dominate the global Nystagmus market owing to the presence of a huge patient population with eye problem, high healthcare spending, and increasing government support for research & development.    

Europe holds the second largest share of the global Nystagmus market as result of increasing focus of various government agencies on the treatment of eye diseases. Moreover, the growing public awareness about Nystagmus is likely to boost the European market.  

The Asia Pacific region is expected to be the fastest growing region and is anticipated to compete with the American and European region during the forecasted period 2017-2023. Japan holds the major share of the regional market due to the availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development is projected to drive the market in China and India over the forecasted period.   

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The U.A.E., Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth. 

Market Overview:

Increasing prevalence of rare diseases, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds are driving the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the period, 2017-2023.

The global Nystagmus market is expected to grow at a CAGR of ~6.2 % during the forecast period 2017-2023. According to the Association for Research in Vision and Ophthalmology (2012), the prevalence of Nystagmus was estimated to be 24.0 per 10,000 population across the globe. The study identified the following as the most common forms of Nystagmus; neurologic Nystagmus (6.8 per 10,000 population), Nystagmus associated with low vision such as congenital cataracts (4.2 per 10,000), and Nystagmus associated with retinal diseases

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/5441

Segmentation:

The Nystagmus market is segmented on the basis of type, diagnosis, treatment, and end-users.

Based on the type, the market is segmented into infantile, latent nystagmus, noonan syndrome, and nystagmus blockage syndrome.

On the basis of the diagnosis, the market is segmented into CT scan, MR scan, chromosome analysis, ultrasonography, and others.

On the basis of the treatment, the market is segmented into medications, surgical, and others.

On the basis of the end-user, the market is segmented into hospitals & clinics, research centers, specialty eye clinics, and others.

Key Players:

Some of key the players in the global Nystagmus market are Bristol-Myers Squibb Company, NUSAPURE, ALLERGAN, Aerie Pharmaceuticals, Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Bayer AG, Genentech, Inc., Novartis AG , Regeneron Pharmaceuticals, Inc., Shire, and Santen Pharmaceutical Co., Ltd., and others.

Brows More Healthcare Related Research Reports:

Duloxetine Intermediate and Atorvastatin Intermediates Market by Forecast – 2023 | MRFR

Lancet and Pen Needles Market Trends Analysis, Growth | Size Value, 2027

Microfluidic Devices Market Size Analysis, Trends | Share Value, 2025

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Calciphylaxis Treatment Market Share, Trend, Challenges, Segmentation

 Calciphylaxis Market Information: By Diagnosis (Deep Skin Biopsies, Blood Tests and Imaging), Treatment, (Intensive Wound Care, Medication, Therapy, and Clot-Dissolving), End User (Hospitals, Clinics, Medical Research Centers) - Global Forecast till 2023

Regional Analysis

Asia Pacific consists of Japan, China, India, Australia, Republic of Korea, and rest of Asia Pacific. Increasing incidence of chronic kidney failure across Asia Pacific. Moreover, the growth of this segment is attributed to high population growth, increasing environmental pollution, and urbanization. Increasing incidence of calciphylaxis, improving healthcare infrastructure and rising awareness about the treatment process have spurred the growth of Calciphylaxis Market in Asia Pacific region.  

Europe consists of two regions namely Western Europe and Eastern Europe. Western Europe consists of countries namely Germany, the U.K., France, Italy, Spain, and Rest of Western Europe. Increasing prevalence of cardiovascular calcification in ESRD patients is a key driver for the growth of this market in Europe. Moreover, increasing healthcare expenditure, rising research & development activities, awareness among patients about the treatment options supporting the market growth for calciphylaxis.

The Americas account for a major share of the market owing to the presence of patient population, well-developed technology, high healthcare expenditure and the presence of the leading players. Moreover, due to the high prevalence of end stage renal diseases (ESRD) on of the major cause of calciphylaxis in U.S. As per The Regents of the University of California, the rate of ESRD is increasing in the U.S. by 5% per year. The American calciphylaxis market is expected to reach USD 1,257 million by 2023 from USD 581.9 million in 2016.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/3567

On the other hand, the Middle East & Africa owns the minimum market share of the calciphylaxis market due to less development in the healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.

Market Highlights

These include bisphosphonates, newer non-calcium/non-aluminum-containing phosphate binders and case reports of use of cinacalcet. Other treatments for calcific uremic arteriolopathy (CUA) that are not targeted directly at calcium/phosphate homeostasis include HBOT and the sodium thiosulphate.  The healthcare professionals have stated that randomized controlled trials for treatments in CUA are still lacking, which has restrained the growth of the market.

Warfarin is most commonly prescribed cardiovascular agent. However, excess use of anticoagulant increases the risk of calciphylaxis in treatment seeking population. According to the national pharmaceutical regulatory agency (2015), cases of calciphylaxis have been reported in patients on warfarin therapy. Although many of the cases reported for pre-existing renal disease.

A number options are available in the market for the treatment of calciphylaxis, which is associated with hypophosphatemia, and secondary hyperparathyroidism with chronic kidney disease.  European Medicine Agency review concluded that there is reasonable possibility between calciphylaxis and use of warfarin.

Major Players in the Calciphylaxis Market

Some of the key players in this market are Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, ConvaTec Inc, Sanifit, and others.

The Global Calciphylaxis Market is expected to grow at a CAGR of 10.70% during the forecast period 2017-2023. Warfarin is an oral anticoagulant which inhibits the synthesis of vitamin K- dependent clotting factors.

Segmentation

The global Calciphylaxis Market is segmented on the basis of diagnosis, treatment, and end user. On the basis of the diagnosis, the calciphylaxis market is further segmented into deep skin biopsies, blood tests, imaging, and others. The deep skin biopsies are further segmented into shave biopsy, punch biopsy, and excisional biopsy. The blood tests is further segmented into serum parathormone levels, blood glucose levels, BUN (blood urea nitrogen), calcium levels, and others. Imaging is further segmented into magnetic resonance imaging (MRI), CT scan, ultrasound, and others. On the basis of the applications, the market is segmented into intensive wound care, medication, therapy, clot-dissolving, and others. Intensive wound care unit is further segmented into debridement, wet dressings, and others. The medication is further segmented into cinacalcet, sodium thiosulfate, steroids, and bisphosphonates. On the basis of end user, it is segmented into hospitals, clinics, medical research centers, academic institutes, and others.

Brows More Healthcare Related Research Reports:

RF Microneedling market Research Report - Forecast to 2023 | MRFR

Eye Allergy Treatment Market Size, Application | Share Analysis, 2023

Healthcare Regulatory Affairs Outsourcing Market Share, Trends | Application and Growth Analysis, 2023

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 524/528, Amanora Chambers

Magarpatta Road, Hadapsar

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email:  sales@marketresearchfuture.com

Fetal Macrosomia Market Size, Share, Demand and Growth

 Fetal Macrosomia Market Growth And Trends Analysis By Diagnosis (Ultrasound, Antenatal Testing, And Others), By Treatment (Medical Care, Surgical Care, And Others), By End User- Global Forecast Till 2023

Overview

Fetal Macrosomia Market Segmentation:

Global Fetal Macrosomia Market has been segmented on the basis of diagnosis which comprise of ultrasound, antenatal testing, and others. Ultrasound is further sub-segmented into standard ultrasound, transvaginal scan, fetal echocardiography, 3-d ultrasound, dynamic 3-d ultrasound, and others. Antenatal testing is further sub-segmented into blood and urine tests, amniocentesis, chorionic villus sampling, and others.

On the basis of treatments, the market has been segmented into medical care, surgical care, and others. Surgical Care is sub-segmented into cesarean delivery, and others.

On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/4002

Fetal Macrosomia Market Highlights

The global fetal macrosomia market has been evaluated as a steady market and it is expected to continue growing soon. Increasing incidence of fetal macrosomia is the major driver for this market. Introduction and increasing adoption of advanced diagnostic tools for effective diagnostic and treatment management is another important factor for the market growth.

The Fetal Macrosomia Market to reach around USD 2290.2 million in 2016 and is expected to reach USD 3034.1 million by 2023 which is a projected CAGR of 4.1%. Companies are investing in development of new and innovative device development is also key driver for the market growth. Major players in fetal macrosomia market: There are plenty of large and small market players which operate in this market: Carestream Health (US),  Esaote SpA (Italy),  Fonar Corporation (US),  Fujifilm Holdings Corporation (Japan),  GE Healthcare (UK),  Hitachi Medical Corporation (Japan),  Hologic, Inc. (US),  Philips Healthcare (Netherlands),  Samsung Medison Co. Ltd (Republic of Korea),  Shimadzu Corporation (Japan),  Siemens Healthcare (Germany),  Toshiba Corporation (Japan),) and others.

Fetal Macrosomia Market Regional Analysis:

Eastern European countries are also showing significant growth in this Fetal Macrosomia Market. Asia Pacific market is witnessing rapid growth due to increasing awareness of the diseases, increasing spending and government initiative to increase awareness as well as to provide affordable healthcare. Talking about the market scenario of Middle East & Africa, this region is expected to grow slower than the global average due to various inhibiting factors such as lack of knowledge, limited access to the required healthcare facilities, traditional healthcare facilities etc.

America is the largest market for fetal macrosomia. The Americas mainly include North America and South America. North America is holding the largest market share in which US is dominating this market. Some major factors like advanced diagnostic and treatment facilities, rapid adoption of healthcare practices, and increasing investment in research are the driving forces for the growth for North America fetal macrosomia market. European region is the second important market, especially West European countries are dominating this region.

Brows More Healthcare Related Research Reports

Care Management Solutions Market Research Report –Global Forecast to 2023| MRFR

Leukapheresis Products Market Research Report - Forecast to 2023 | MRFR

Facial Injectors Market Research Report - Forecast to 2023 | MRFR

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Drug Infusion System Market Analysis, Landscape and Growth Prospects

Global Drug Infusion System Market Research Report, by Product Type (Elastomeric Infusion System, Disposable Infusion System), by Application (Oncology/Chemotherapy), Mode of Administration (Intravenous), End-User (Hospitals) - Global Forecast Till 2023

Regional Analysis

The Americas dominated the global drug infusion system market in 2017. This can be attributed due to the rising incidence of chronic diseases like cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis within the region provides favorable backgrounds for market growth. According to the American Heart Association (2018), 92.1 million Americans suffer from some form of the cardiovascular disease. Also, the presence of major market players such as Medtronic and Becton, Dickinson and Company within the region influences the market growth.  

Europe (the UK, Belgium, France & Netherlands) is second in the market owing to increasing healthcare expenditure, and rising prevalence of chronic respiratory diseases is expected to influence the market in this region. According to Eurostat in 2014, 382 thousand deaths were due to chronic respiratory diseases in the European Union (EU). Thus, the rise in chronic respiratory diseases favors the growth of the market in this region.

Asia Pacific is expected to observe the fastest growth for the global Drug infusion system market owing to a growing geriatric population in this region. The Asian Development Bank (ADB) projected that in 2050 the geriatric population is expected to reach 923 million. This offers potential growth opportunities in this region.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/6207

Segmentation

The global drug infusion system market is segmented on the basis of product type, mode of administration, application, and end-user. The drug infusion system market, is sub-segmented into Elastomeric infusion system, Disposable infusion system, Syringe infusion system, Peristaltic pump, Multi-channel pump, Patient-controlled analgesia (PCA) pump, Insulin pump and Implantable infusion system.

On the basis of Application, the market is categorized into Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, and others. Mode of administration is further sub-segmented into Intravenous, Subcutaneous, Arterial, Epidural and Others. By end-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic centers and others.

Key Players

Some of the key players for the global drug infusion system market are Medtronic, Arcomed AG, B. Braun Melsungen AG, Baxter, Becton Dickinson and Company, Debiotech S.A., Fresenius SE & Co. KGaA, Halyard Health, Inc, ICU Medical Inc, IRadimed Corporation, Insulet Corporation, Terumo Corporation, Smiths Group plc, Tandem Diabetes care, MOOG INC., and others.

Market Highlights

The increase in the prevalence of chronic diseases such as cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis drives the market growth. Furthermore, adoption of technologically advanced devices and the rising geriatric population are the key factors for the market to grow. However, factors such as the high cost of drug infusion system, shortage of skilled labor and stringent government rules and regulations for product approval are expected to restrict the market growth during the forecast period.

Brows More Healthcare Related Research Reports:

Micropump Market by Share, Size, Growth and Analysis – 2024 | MRFR

Mastitis Market by Type, Share, Growth and Analysis – 2023 | MRFR

Percutaneous Coronary Intervention Market by Growth and Forecast – 2023 | MRFR

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com